Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1999
10/21/1999WO1999052941A2 Polypeptide domains capable of binding rho protein and their use in assays
10/21/1999WO1999052940A1 Method for extracting, identifying, using active principles of marine mollusque shells
10/21/1999WO1999052939A1 Peptides
10/21/1999WO1999052938A2 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
10/21/1999WO1999052936A2 Arginine peptide analogs useful as fibroblast growth factor antagonists
10/21/1999WO1999052933A1 Process for the preparation of resin-bound cyclic peptides
10/21/1999WO1999052929A1 Nucleic acid sequences and proteins associated with aging
10/21/1999WO1999052928A1 Transporter protein splice variants and model for immune diversity
10/21/1999WO1999052927A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999WO1999052926A1 Regulated target expression for screening
10/21/1999WO1999052924A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999WO1999052563A1 A method for the targeting of proteins produced by yersinia into the cytosol of eukaryotic cells
10/21/1999WO1999052552A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999WO1999052548A2 Conjugate vaccines for the prevention of dental caries
10/21/1999WO1999052545A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052539A1 Neo-tryptophan
10/21/1999WO1999052415A2 Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor
10/21/1999WO1999052349A1 Hiv transgenic animals and uses therefor
10/21/1999WO1999047654A3 Combination of genes for regulating flowering induction in useful and ornamental plants
10/21/1999WO1999046574A3 Antibodies for assessing protein post-translational modification status and methods of making and using the same
10/21/1999WO1999046396A3 Glyphosate as a gametocide
10/21/1999WO1999046386B1 ALK-1 RESPONDS TO TGF-β AND SIGNALS THROUGH SMAD-1 AND SMAD-5
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999046298A3 Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments
10/21/1999WO1999045894A3 Cosmetic compositions
10/21/1999WO1999045119A3 Production of mycobacterial polypeptides by lactic acid bacteria
10/21/1999WO1999042598A3 Hybrid seed production
10/21/1999WO1999042577A3 Biotin-binding receptor molecules
10/21/1999WO1999042474A3 Method for designing dna-binding proteins of the zinc-finger class
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999041415A9 Transposable element-anchored, amplification method for isolation and identification of tagged genes
10/21/1999WO1999040114A9 Novel gabab receptor dna sequences
10/21/1999WO1999040113A9 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
10/21/1999WO1999038980A9 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
10/21/1999WO1999037794A8 Methods and composition for modulating flavonoid content
10/21/1999WO1999036553A3 Regulation of biological events using multimeric chimeric proteins
10/21/1999WO1999036530A3 Lh-receptor gene promoter for tissue-specific gene expression
10/21/1999WO1999036529A3 Twik-1 related two p domains potassium channel
10/21/1999WO1999035170A8 Compositions and methods for the treatment of tumor
10/21/1999WO1999033870A3 Human regulatory proteins
10/21/1999WO1999032643A3 Mood disorder gene
10/21/1999WO1999032428A8 Synthesis of diamines
10/21/1999WO1999030738A3 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/21/1999WO1999030157A9 Neuropilins in methods for diagnosis and prognosis of cancer
10/21/1999WO1999024607A3 DETECTION AND TYPING OF THE iceA GENE OF $i(HELICOBACTER PYLORI)
10/21/1999WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999WO1998041625A8 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
10/21/1999DE19818598A1 New nucleic acid sequences expressed in normal pancreatic tissues, and derived polypeptides, for treatment of pancreatic cancer and identification of therapeutic agents
10/21/1999DE19817948A1 New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents
10/21/1999DE19817946A1 New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents
10/21/1999DE19817557A1 Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe Human nucleic acid sequences from Ovartumorgewebe
10/21/1999DE19816186A1 GDNF-kodierende DNA, Teile davon und GDNF-Varianten GDNF-coding DNA, parts thereof and GDNF variants
10/21/1999DE19806581A1 Sequenzen eines Ih-Ionenkanals und deren Verwendung Sequences of Ih ion channel and their use
10/21/1999CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999CA2402599A1 Programmed cell death and caspase-12
10/21/1999CA2328725A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999CA2328461A1 Flowering locus t (ft) and genetically modified plants having modulated flower development
10/21/1999CA2328157A1 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway
10/21/1999CA2327882A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
10/21/1999CA2327109A1 Adhesives
10/21/1999CA2325817A1 Transgenic mammals expressing mutant gp iiia
10/21/1999CA2325658A1 Gene coding for heliomicine and use thereof
10/21/1999CA2325603A1 Pns cell lines and methods of use therefor
10/21/1999CA2325602A1 Regulated target expression for screening
10/21/1999CA2325601A1 Novel constructs for controlled expression of recombinant proteins in prokaryotic cells
10/21/1999CA2325576A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine
10/21/1999CA2325572A1 Process for the preparation of resin-bound cyclic peptides
10/21/1999CA2325565A1 Diagnosis of multiple sclerosis and other demyelinating diseases
10/21/1999CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999CA2325560A1 Noncloning technique for expressing a gene of interest
10/21/1999CA2325559A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999CA2325390A1 Human stanniocalcin and uses thereof to inhibit adipogenesis
10/21/1999CA2325338A1 Conjugate vaccines for the prevention of dental caries
10/21/1999CA2325332A1 Therapeutic agent for ngf
10/21/1999CA2325330A1 Transferrin receptor genes of moraxella
10/21/1999CA2325057A1 Secreted proteins and polynucleotides encoding them
10/21/1999CA2325022A1 Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence
10/21/1999CA2324992A1 U4, a member of the hematopoietin receptor superfamily
10/21/1999CA2324981A1 Peptides
10/21/1999CA2324870A1 Modified biological material
10/21/1999CA2324480A1 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999CA2324376A1 Seed specific polycomb group gene and methods of use for same
10/21/1999CA2323934A1 Nucleic acid sequences and proteins associated with aging
10/21/1999CA2323789A1 Expression of alfin1 and methods for producing transgenic plants having increased root growth and root specific gene activation
10/21/1999CA2323107A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999CA2319089A1 5' ests and encoded human proteins
10/21/1999CA2294018A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
10/20/1999EP0950713A2 Recombinant adenoviral vector for gene transfer
10/20/1999EP0950712A1 Yeast vectors and process for producing proteins with the use of the same
10/20/1999EP0950711A2 Gonadotropin receptor
10/20/1999EP0950710A2 Cells expressing a chimera receptor and their uses
10/20/1999EP0950709A1 Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
10/20/1999EP0950708A2 Enhanced affinity hyaluronan binding peptides
10/20/1999EP0950707A1 Homologous recombination for universal donor cells and chimeric mammalian hosts
10/20/1999EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999EP0950665A1 Modified physiologically active proteins and medicinal compositions containing the same
10/20/1999EP0950663A1 Method for stabilizing useful proteins and useful protein compositions
10/20/1999EP0950189A1 Brca1 associated protein (bap-1) and uses therefor
1 ... 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 ... 2916